{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-22-000019","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2022-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.387102+00:00","generated_at":"2026-06-24T21:31:25.296962+00:00","sec_items":["1.01","1.02","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vertex enters new $500M senior unsecured revolving credit facility, replaces 2019 agreement","bullets":["$500M revolving facility, matures July 1, 2027; capacity can be increased by an additional $500M.","Interest: base rate +0.000%-0.500% or SOFR +1.000%-1.500%, based on leverage ratio or credit rating.","Financial covenant: consolidated leverage ratio ≤3.50:1 (4.00:1 after material acquisition).","Old 2019 credit agreement terminated and all obligations repaid; related guarantees released."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-22-000019","json":"https://secwatch.observer/filing/0000875320-22-000019.json","markdown":"https://secwatch.observer/filing/0000875320-22-000019.md","text":"https://secwatch.observer/filing/0000875320-22-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/0000875320-22-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/vrtx-20220701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:31:25.296962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}